Clin Mol Hepatol.
2025 Jan;31(1):e8-e9. 10.3350/cmh.2024.0958.
Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
- Affiliations
-
- 1Department of Hematology, Wenzhou Medical University Affiliated Dongyang Hospital, Jinhua, Zhejiang, China
- KMID: 2563413
- DOI: http://doi.org/10.3350/cmh.2024.0958
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma
- Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Radiofrequency Ablation for Hepatocellular Carcinoma
- Metabolic Dysfunction-associated Steatotic Liver Disease– related Hepatocellular Carcinoma: Current Research Insights
- Personalized approaches to the treatment of hepatocellular carcinoma using immune checkpoint inhibitors: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
